Cerium Pharmaceuticals, Inc. research brief
CIK 1677995
Generated Nov. 18, 2026, 5:25 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: GAITHERSBURG Maryland. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 6, 2026 · D · 0001677995-26-000003 · Source evidence
Reported offering amount: 2544000 USD. Reported amount sold: 750000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Cerium Pharmaceuticals, Inc. research brief,” CIK 1677995, retrieved Nov. 18, 2026, 5:25 a.m.. Cite the specific accessions used. No amounts have been summed.